MwanzoALCOX • EPA
add
NicOx SA
Bei iliyotangulia
€ 0.30
Bei za siku
€ 0.30 - € 0.32
Bei za mwaka
€ 0.14 - € 0.49
Thamani ya kampuni katika soko
21.11M EUR
Wastani wa hisa zilizouzwa
elfu 200.70
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
EPA
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (EUR) | Jun 2023info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 866.50 | — |
Matumizi ya uendeshaji wa biashara | 1.75M | — |
Mapato halisi | -3.30M | — |
Kiwango cha faida halisi | -381.19 | — |
Mapato kwa kila hisa | — | — |
EBITDA | -4.17M | — |
Asilimia ya kodi ya mapato | -0.30% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (EUR) | Jun 2023info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 19.01M | — |
Jumla ya mali | 82.28M | — |
Jumla ya dhima | 36.75M | — |
Jumla ya hisa | 45.53M | — |
hisa zilizosalia | 50.15M | — |
Uwiano wa bei na thamani | 0.33 | — |
Faida inayotokana na mali | -12.84% | — |
Faida inayotokana mtaji | -15.84% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (EUR) | Jun 2023info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -3.30M | — |
Pesa kutokana na shughuli | -4.16M | — |
Pesa kutokana na uwekezaji | elfu -19.50 | — |
Pesa kutokana na ufadhili | elfu -135.00 | — |
Mabadiliko halisi ya pesa taslimu | -4.32M | — |
Mtiririko huru wa pesa | -2.86M | — |
Kuhusu
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
Ilianzishwa
1996
Makao Makuu
Tovuti
Wafanyakazi
5
